Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Times Interest Earned (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Times Interest Earned for 3 consecutive years, with -$357.68 as the latest value for Q3 2025.

  • On a quarterly basis, Times Interest Earned fell 1250.88% to -$357.68 in Q3 2025 year-over-year; TTM through Sep 2025 was -$77.42, a 165.91% decrease, with the full-year FY2024 number at -$34.57, down 250.52% from a year prior.
  • Times Interest Earned was -$357.68 for Q3 2025 at Mereo BioPharma, up from -$437.46 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$0.79 in Q2 2023 to a low of -$437.46 in Q2 2025.
  • A 3-year average of -$94.86 and a median of -$31.94 in 2024 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: plummeted 4811.92% in 2024, then plummeted 94.87% in 2025.
  • Mereo BioPharma's Times Interest Earned stood at -$20.25 in 2023, then tumbled by 101.15% to -$40.73 in 2024, then tumbled by 778.1% to -$357.68 in 2025.
  • Per Business Quant, the three most recent readings for MREO's Times Interest Earned are -$357.68 (Q3 2025), -$437.46 (Q2 2025), and -$62.23 (Q1 2025).